comparemela.com

Latest Breaking News On - Global vaccine business unit - Page 5 : comparemela.com

FDA grants priority review to Takeda s BLA for dengue vaccine candidate

The US FDA has accepted and granted priority review to Takeda’s BLA for its investigational dengue vaccine candidate, TAK-003.

Takeda s Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U S Food and Drug Administration

OSAKA, Japan and CAMBRIDGE, Massachusetts - Takeda announced that the U.S. Food and Drug Administration has accepted and granted priority review of the Biologics License Application for TAK-003,. | November 23, 2022

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.